BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8274141)

  • 1. Common mechanisms for the control of eukaryotic transcriptional elongation.
    Krumm A; Meulia T; Groudine M
    Bioessays; 1993 Oct; 15(10):659-65. PubMed ID: 8274141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV trans-activation and transcription control mechanisms.
    Jones KA
    New Biol; 1989 Nov; 1(2):127-35. PubMed ID: 2562218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional antitermination.
    Greenblatt J; Nodwell JR; Mason SW
    Nature; 1993 Jul; 364(6436):401-6. PubMed ID: 8332211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tackling Tat.
    Karn J
    J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the position of TAR on transcriptional activation by HIV-1 Tat in vivo.
    Wright S; Luccarini C
    J Mol Biol; 1996 Oct; 263(1):1-7. PubMed ID: 8890908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular approaches to inhibit HIV-1 tat expression and functions.
    Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
    Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
    Marcello A; Zoppé M; Giacca M
    IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex.
    Liu Y; Suñé C; Garcia-Blanco MA
    Virology; 1999 Mar; 255(2):337-46. PubMed ID: 10069959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Tat: coping with negative elongation factors.
    Garber ME; Jones KA
    Curr Opin Immunol; 1999 Aug; 11(4):460-5. PubMed ID: 10448148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of c-fos expression by RNA polymerase elongation competence.
    Pinaud S; Mirkovitch J
    J Mol Biol; 1998 Jul; 280(5):785-98. PubMed ID: 9671550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
    J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
    Taube R; Fujinaga K; Wimmer J; Barboric M; Peterlin BM
    Virology; 1999 Nov; 264(2):245-53. PubMed ID: 10562489
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ; Karn J
    EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
    Rana TM; Jeang KT
    Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitation of Tat-associated transcriptional processivity in HIV-infected PBMC.
    Adams M; Wong C; Wang D; Romeo J
    Virology; 1999 May; 257(2):397-405. PubMed ID: 10329550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the promoter can influence assembly of antitermination complexes at downstream RNA sites.
    Zhou Y; Shi T; Mozola MA; Olson ER; Henthorn K; Brown S; Gussin GN; Friedman DI
    J Bacteriol; 2006 Mar; 188(6):2222-32. PubMed ID: 16513752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA.
    Zhou M; Deng L; Kashanchi F; Brady JN; Shatkin AJ; Kumar A
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12666-71. PubMed ID: 14569024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.